According to Kefu Medical's announcement, the company plans to use centralized bidding to repurchase A-shares to cancel capital cuts. The repurchase amount is not less than 100 million yuan and no more than 200 million yuan. The upper limit of the repurchase price was adjusted to 69.09 yuan/share due to the implementation of mid-term dividends. The repurchase period is within 12 months from the date of review and approval by the shareholders' meeting. As of September 30, 2026, the company had repurchased 2,516,900 shares, accounting for 1.20% of the total share capital of A shares. The highest transaction price was 54.68 yuan/share, the lowest transaction price was 4839 yuan/share, and the total transaction amount was 130 million yuan. Subsequent companies will continue to promote repurchases in line with market conditions.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.